Finance

Lists
300583:SHE
Shandong Sito Bio-technology Co Ltd
CNÂ¥13.70
+0.81%
(+0.11) 1D
Sep 30, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300583...
Open
CNÂ¥13.59
High
CNÂ¥13.80
Low
CNÂ¥13.58
Mkt. cap
2.60B
Avg. vol.
4.80M
Volume
0.00
Dividend
0.11%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 14, 2026
P/E ratio
266.12
52-wk high
CNÂ¥16.27
52-wk low
CNÂ¥10.63
EPS
CNÂ¥0.05
Shares outstanding
189.70M
No. of employees
990
Open
CNÂ¥13.59
High
CNÂ¥13.80
Low
CNÂ¥13.58
Mkt. cap
2.60B
Avg. vol.
4.80M
Volume
0.00
Dividend
0.11%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 14, 2026
P/E ratio
266.12
52-wk high
CNÂ¥16.27
52-wk low
CNÂ¥10.63
EPS
CNÂ¥0.05
Shares outstanding
189.70M
No. of employees
990
News stories
From web sources and news partners
About Shandong Sito Bio-technology Co Ltd
CEO-
Employees990
Founded2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
241.43M
267.68M
328.05M
284.69M
Cost of goods sold
184.84M
245.33M
255.61M
206.80M
Cost of revenue
184.84M
245.33M
255.61M
206.80M
Research and development expenses
9.79M
9.29M
10.11M
11.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.96M
28.26M
39.48M
28.15M
Operating expense
38.32M
37.45M
55.97M
42.81M
Total operating expenses
223.17M
282.78M
311.59M
249.61M
Operating income
18.26M
-15.10M
16.46M
35.07M
Other non operating income
805.63K
-3.36M
-2.78M
2.04M
EBT including unusual items
-17.69M
-1.86M
6.46M
34.10M
EBT excluding unusual items
15.39M
-25.68M
9.20M
29.47M
Income tax expense
1.60M
3.69M
1.89M
7.71M
Effective tax rate
-9.04%
-197.99%
29.20%
22.62%
Other operating expenses
-3.66M
6.35M
2.97M
4.21M
Net income
-16.54M
-3.92M
3.62M
26.61M
Net profit margin
-6.85%
-1.46%
1.10%
9.35%
Earnings per share
-
-
-
-
Interest and investment income
1.66M
1.36M
385.18K
3.49M
Interest expense
-6.27M
-7.25M
-7.36M
-6.86M
Net interest expenses
-4.61M
-5.89M
-6.98M
-3.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
60.69M
26.17M
57.73M
76.95M
Gain or loss from assets sale
-162.58K
824.30K
-
-217.91K
AI content may include mistakes. Learn more
Google apps